{"SLR NAME":"Corona Virus Disease 2019 (COVID-19) and Its Effect on Renal System, A Systematic Review and Meta-analysis","References":[{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Children with respiratory disease associated with metapneumovirus in Hong Kong"},{"title3":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay"},{"title3":"Characterization of human metapneumoviruses isolated from patients in North America"},{"title3":"Chan PKS, Tam JS, Lam CW, etal. Detection of human metapneumovirus from patients with severe acute respiratory syndrome: a methodological evaluation. Emerg Infect Dis (in press)."},{"title3":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene"},{"title3":"Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction"},{"title3":"Rapid and standardised detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR"},{"title3":"A newly discovered human metapneumovirus isolated from young children with respiratory tract disease"},{"title3":"Experimental infection of adult axenic rats with Parker's rat coronavirus"},{"title3":"Pathogenicity of experimental infection with 'pneumotropic' porcine coronavirus"},{"title3":"Pathogenicity of porcine respiratory coronavirus isolated in Quebec"},{"title3":"Measles virus and immunomodulation: molecular bases and perspectives"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Life experiences and support perceived by nurses in hospital haemodialysis units during the COVID-19 pandemic in Spain"},{"title3":"Connecting with generation Z: Approaches in nursing education"},{"title3":"Qualitative descriptive methods in health science research"},{"title3":"The characteristic of generation Z"},{"title3":"Nurses at the front line of COVID-19: Roles, responsibilities, risks, and rights"},{"title3":"Implications for COVID-19: A systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic"},{"title3":"Exploring nurses' experiences of psychological distress during care of patients with COVID-19: A qualitative study"},{"title3":"Novice nurse's transitioning to emergency nurse during COVID-19 pandemic: A qualitative study"},{"title3":"Generation Z students: Will they change our nursing classrooms?"},{"title3":"Novice nurses' experiences of unpreparedness at the beginning of the work"},{"title3":"Frontline nurses' burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study"},{"title3":"New graduate nurses' experiences in a clinical specialty: A follow up study of newcomer perceptions of transitional support"},{"title3":"Experiences and psychosocial problems of nurses caring for patients diagnosed with COVID-19 in Turkey: A qualitative study"},{"title3":"Final clinical practicum, transition experience and turnover intentions among newly graduated nurses: A cross sectional study"},{"title3":"The impact of human resource development on organizational effectiveness: An empirical study"},{"title3":"The lived experience of nurses caring for patients with COVID-19 in Iran: A phenomenological study"},{"title3":"The experiences of health-care providers during the COVID-19 crisis in China: A qualitative study"},{"title3":"Experiences of nurses during the COVID-19 pandemic: A mixed-methods study"},{"title3":"Rapid deployment of critical care nurse education during the COVID-19 pandemic"},{"title3":"Effective orientation programs for new graduate nurses: A systematic review"},{"title3":"Exploring nursing managers' perceptions of nursing workforce management during the outbreak of COVID-19: A content analysis study"},{"title3":"Coronavirus infectious disease-2019 (COVID-19): A case report, the first patient in Thailand and outside China"},{"title3":"Nursing experiences of COVID-19 outbreak in Iran: A qualitative study"},{"title3":"Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic"},{"title3":"Deciding about the use of a personal safety alerting device:The need for a legitimation process: A qualitative study"},{"title3":"Nurses on the frontline against the COVID-19 pandemic: An integrative review"},{"title3":"The impact of human resource development (HRD) practices on organizational effectiveness: A review"},{"title3":"Holistic care for patients with severe coronavirus disease 2019: An expert consensus"},{"title3":"The experience of transition from nursing students to newly graduated registered nurses in Singapore"},{"title3":"Nurses' psychological changes and coping strategies during home isolation for the 2019 novel coronavirus in China: A qualitative study"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"WHO. WHO coronavirus (COVID-19) (2022) dashboard https://covid19.who.int/"},{"title3":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study"},{"title3":"A review on COVID-19 forecasting models"},{"title3":"Predictive models of COVID-19 in India: A rapid review"},{"title3":"Forecasting the spread of COVID-19 under different reopening strategies"},{"title3":"A modified age-structured SIR model for COVID-19 type viruses"},{"title3":"Inefficiency of SIR models in forecasting COVID-19 epidemic: A case study of Isfahan"},{"title3":"Baek, J. et al. (2020) The limits to learning an sir process granular for COVID-19. Preprint at arXiv:2006.06373v1"},{"title3":"Quantifying the time-lag effects of human mobility on the COVID-19 transmission: A multi-city study in China"},{"title3":"The effect of population mobility on COVID-19 incidence in 314 Latin American cities: A longitudinal ecological study with mobile phone location data"},{"title3":"Changes in social environment due to the state of emergency and go to campaign during the COVID-19 pandemic in Japan: An ecological study"},{"title3":"The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan"},{"title3":"Mobility network models of COVID-19 explain inequities and inform reopening"},{"title3":"Commentary on Ferguson, et al., impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand"},{"title3":"Member of WIN and Gallup International Association. (2022) NR YouGov information https://www.nrc.co.jp/nryg/211227.html"},{"title3":"The &lt;Three Cs&gt; of Japan's pandemic response as an ideograph"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Agent-based modeling for super-spreading events: A case study of MERS-CoV transmission dynamics in the Republic of Korea"},{"title3":"Mobility change and COVID-19 in Japan: Mobile data analysis of locations of infection"},{"title3":"Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic"},{"title3":"Reduction in mobility and COVID-19 transmission"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan"},{"title3":"Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant"},{"title3":"Association between mobility patterns and COVID-19 transmission in the USA: A mathematical modelling study"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in china"},{"title3":"Ogiwara, K. (2021) Coronavirus disease (COVID-19) situation report in Japan https://toyokeizai.net/sp/visual/tko/covid19/en.html"},{"title3":"Tokyo Metropolitan Government. (2020) Number of Ovid-19 positive cases by date of onset https://stopcovid19.metro.tokyo.lg.jp/cards/positive-number-by-developed-date/"},{"title3":"Number of subscribers by carriers. (2021) Webpage in Japanese. Telecommunications Carriers Association. https://www.tca.or.jp/database/"},{"title3":"A contribution to the mathematical theory of epidemics"},{"title3":"The approximately universal shapes of epidemic curves in the Susceptible-Exposed-Infectious-Recovered (SEIR) model"},{"title3":"Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions"},{"title3":"A cluster analysis method for grouping means in the analysis of variance"},{"title3":"Geometric interpretation of gene coexpression network analysis"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks"},{"title3":"Toyo Keizai Online The novel coronavirus diseaseDisease (COVID-19) Situation Report in Japan. https://toyokeizai.net/sp/visual/tko/covid19/en.html."}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Early Epidemiological and Clinical Characteristics of 28 cases of Coronavirus Disease in South Korea"},{"title3":"Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea"},{"title3":"Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea"},{"title3":"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"title3":"Identification of coronavirus isolated from a patient in Korea with COVID-19"},{"title3":"A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series."},{"title3":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019."},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection."},{"title3":"Clinicopathologic study of thirty-three fatal cases of Asian influenza."},{"title3":"Observations on the A2 England influenza epidemic: A clinicopathological study."},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection."},{"title3":"2009 pandemic H1N1-associated myocarditis in a previously healthy adult."},{"title3":"Influenza myocarditis and myositis: Case presentation and review of the literature."},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care."},{"title3":"Cardiac complications of influenza infection in 3 adults."},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection."},{"title3":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care."},{"title3":"Influenza, autoimmunity and atherogenesis."},{"title3":"Cardiovascular manifestations associated with influenza virus infection."},{"title3":"The cardiovascular manifestations of influenza: a systematic review."},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection."},{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review."},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)."},{"title3":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients."},{"title3":"Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension."},{"title3":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography."},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"KDIGO clinical practice guidelines for acute kidney injury."},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia."},{"title3":"A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support."},{"title3":"Acute cardiac injury events &lt;=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Transient cardiac injury during H7N9 infection."},{"title3":"Relation of concomitant heart failure to outcomes in patients hospitalized with influenza."},{"title3":"Extreme influenza epidemics and out-of-hospital cardiac arrest."},{"title3":"Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study."},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis."},{"title3":"Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations."},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection."},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09."},{"title3":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG."},{"title3":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: Results of two international observational cohort studies."},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?"},{"title3":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction."},{"title3":"Acute infection and myocardial infarction."},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection."},{"title3":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Jan 2018."},{"title3":"Middle East Respiratory Syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A review of treatment modalities for Middle East Respiratory Syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis"},{"title3":"Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study"},{"title3":"Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS)"},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Abbott Laboratories. Product Information: Kaletra . https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021226s030lbl.pdf. Accessed 14 Jan 2018."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"SPIRIT 2013 statement: defining standard protocol items for clinical trials"},{"title3":"Chang, M. Adaptive Design Theory and implementation using SAS and R, 2nd ed. Chapman and Hall/CRC. 2014. Pp. 153-180."},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, 39, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39)."},{"title3":"Classification of acute pancreatitis:2012: revision of the Atlanta classification and definitions by international consensus"},{"title3":"Evaluating cancer patients for rehabilitation potential"},{"title3":"U.S. National Library of Medicine. LiverTox. https://livertox.nlm.nih.gov//Lopinavir.htm. Accessed 14 Jan 2018."},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Uniform requirements for manuscripts submitted to biomedical journals"},{"title3":"PubMed-cited research articles on the Middle East respiratory syndrome"},{"title3":"Non-randomised Ebola trials:lessons for optimal outbreak research"},{"title3":"Conducting research in disease outbreaks"},{"title3":"Modification of the sample-size and the schedule of interim analyses in survival trials based on data inspections"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"MERS-CoV Antibodies in Humans, Africa, 2013-2014"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New Metrics for Evaluating Viral Respiratory Pathogenesis"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Viral Load Kinetics of MERS Coronavirus Infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"Dudas, G., Carvalho, L. M., Rambaut, A. &amp; Bedford, T. MERS-CoV spillover at the camel-human interface. eLife7, e31257 (2018)."},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (2018)."},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Kaletra. Highlights of Prescribing Information. https://www.rxabbvie.com/pdf/kaletratabpi.pdf (2017)."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Arabi, Y. M. Twitter account for MIRACLE Trial. (2019)."},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase"},{"title3":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. &amp; Gotte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses11, 326 (2019)."},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors"},{"title3":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease"},{"title3":"Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Arabi, Y. M. MERS-CoV infection treated with a combination of lopinavir/ritonavir and interferon beta-1b (MIRACLE). https://clinicaltrials.gov/ct2/show/NCT02845843 (2016)."},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection"},{"title3":"Lossi, L., Castagna, C. &amp; Merighi, A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci.19, 3999 (2018)."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy"},{"title3":"Clinical uses of interferons"},{"title3":"Virus interference. I. The interferon"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness"},{"title3":"The Superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection"},{"title3":"Mouse models of acute respiratory distress syndrome: a review of analytical approaches, pathologic features, and common measurements"},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586. https://clinicaltrials.gov/ct2/show/NCT03719586?term=NCT03719586&amp;draw=2&amp;rank=1 (2019)."},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen NCT02818582. https://clinicaltrials.gov/ct2/show/NCT02818582?term=NCT02818582&amp;draw=2&amp;rank=1 (2019)."},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets"},{"title3":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio9, e00221-18(2018)."},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Betaseron. Highlights of Prescribing Information. https://labeling.bayerhealthcare.com/html/products/pi/Betaseron_PI.pdf (2015)."},{"title3":"A simple practice guide for dose conversion between animals and human"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Host range, prevalence, and genetic diversity of adenoviruses in bats"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Evolutionary relationships between bat coronaviruses and their hosts"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Prediction and prevention of the next pandemic zoonosis"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"First isolation and characterization of bat SARS-like coronaviruses that use the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"SARS-CoV infection in a restaurant from palm civet"}]}]},{"title1":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Coronavirus pathogenesis","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"The coronavirus disease 2019 (COVID-19) pandemic"},{"title3":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?"},{"title3":"COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS"},{"title3":"Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19"},{"title3":"In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19"},{"title3":"Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease"},{"title3":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19"},{"title3":"Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Patterns of inflammatory cell infiltration and expression of STAT6 in the lungs of patients with COVID-19: an autopsy study"},{"title3":"Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation"},{"title3":"The spatial landscape of lung pathology during COVID-19 progression"},{"title3":"A molecular single-cell lung atlas of lethal COVID-19"},{"title3":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis"},{"title3":"The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single cell resolution"},{"title3":"Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures"},{"title3":"Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures"},{"title3":"Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection"},{"title3":"Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Physiology of cardiomyocyte injury in COVID-19"},{"title3":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes"},{"title3":"The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells"},{"title3":"The cross-talk of lung and heart complications in COVID-19: endothelial cells dysfunction, thrombosis, and treatment"},{"title3":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets"},{"title3":"Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry"},{"title3":"SARS-CoV-2 productively infects human brain microvascular endothelial cells"},{"title3":"The good treatment, the bad virus, and the ugly inflammation: pathophysiology of kidney involvement during COVID-19"},{"title3":"Pathophysiology of COVID-19-associated acute kidney injury"},{"title3":"Endothelial dysfunction for acute kidney injury in coronavirus disease 2019: how concerned should we be?"},{"title3":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches"},{"title3":"Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19"},{"title3":"Circulating endothelial cells as a marker of endothelial injury in severe COVID -19"},{"title3":"COVID-19 and the endothelium"},{"title3":"Emerging role of neuropilin-1 and angiotensin-converting enzyme-2 in renal carcinoma-associated COVID-19 pathogenesis"},{"title3":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19"},{"title3":"COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients"},{"title3":"Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement"},{"title3":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Potential specific therapies in COVID-19"},{"title3":"Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets"},{"title3":"A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4"},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Resistance of endothelial cells to SARS-CoV-2 infection in vitro Blerina Ahmetaj-Shala"},{"title3":"The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo"},{"title3":"Evolving functions of endothelial cells in inflammation"},{"title3":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis"}]},{"title2":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin","References":[{"title3":"Host and viral traits predict zoonotic spillover from mammals"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Discovery and genetic analysis of novel coronaviruses in least horseshoe bats in southwestern China"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Porcine deltacoronavirus in mainland China"},{"title3":"Epidemiology and vaccine of porcine epidemic diarrhea virus in China: a mini-review"},{"title3":"Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome"},{"title3":"Molecular epidemiology of porcine epidemic diarrhea virus in China"},{"title3":"Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay"},{"title3":"A new bat-HKU2-like coronavirus in swine, China, 2017"},{"title3":"Discovery of a novel swine enteric alphacoronavirus (SeACoV) in southern China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Masters, P. S. &amp; Perlman, S. in Fields Virology Vol. 2 (eds Knipe, D. M. &amp; Howley, P. M.) 825-858 (Lippincott Williams &amp; Wilkins, Philadelphia, 2013)."},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium"},{"title3":"Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus"},{"title3":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2"},{"title3":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy"},{"title3":"Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Coot: model-building tools for molecular graphics"},{"title3":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega"}]},{"title2":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study","References":[]},{"title2":"Aging and lung disease","References":[{"title3":"European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia"},{"title3":"Bronchopulmonary dysplasia"},{"title3":"Evaluation of neonatal intensive care for extremely-low-birth-weight infants"},{"title3":"Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort"},{"title3":"Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network"},{"title3":"Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation"},{"title3":"Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices"},{"title3":"Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia"},{"title3":"High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity"},{"title3":"Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia"},{"title3":"Capnography in spontaneously breathing preterm infants with bronchopulmonary dysplasia"},{"title3":"The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial"},{"title3":"Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants"},{"title3":"Antenatal inflammation and lung injury: prenatal origin of neonatal disease"},{"title3":"Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates"},{"title3":"Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants"},{"title3":"Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome"},{"title3":"The role of nutrition in the prevention and management of bronchopulmonary dysplasia"},{"title3":"Vitamin A status of neonates with bronchopulmonary dysplasia"},{"title3":"Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia"},{"title3":"Maternal preeclampsia predicts the development of bronchopulmonary dysplasia"},{"title3":"Collaborators of the Hypertensive Disorders of Pregnancy Study G. Preeclampsia predicts higher incidence of bronchopulmonary dysplasia"},{"title3":"Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation"},{"title3":"Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study"},{"title3":"Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age"},{"title3":"Short-term outcome in infants with a birthweight less than 501 grams"},{"title3":"Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks"},{"title3":"Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep"},{"title3":"Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function"},{"title3":"Maternal smoking, intrauterine growth restriction, and placental apoptosis"},{"title3":"Respiratory health in pre-school and school age children following extremely preterm birth"},{"title3":"The 'new' bronchopulmonary dysplasia: challenges and commentary"},{"title3":"Association of lipid peroxidation with antenatal betamethasone and oxygen radial disorders in preterm infants"},{"title3":"Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressure-volume loops in rats"},{"title3":"Reduced life expectancy in rats after neonatal dexamethasone treatment"},{"title3":"Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants"},{"title3":"Microbial exposure during early life has persistent effects on natural killer T cell function"},{"title3":"Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden. (EXPRESS)"},{"title3":"Adverse impact of maternal cigarette smoking on preterm infants: a population-based cohort study"},{"title3":"Familial and genetic susceptibility to major neonatal morbidities in preterm twins"},{"title3":"Genetic influences and neonatal lung disease"},{"title3":"Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants"},{"title3":"Genetic polymorphisms of antioxidant enzymes in preterm infants"},{"title3":"Role of gender in morbidity and mortality of extremely premature neonates"},{"title3":"Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants"},{"title3":"Gender differences in respiratory symptoms in 19-year-old adults born preterm"},{"title3":"Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network"},{"title3":"Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops"},{"title3":"Inflammation and bronchopulmonary dysplasia: a continuing story"},{"title3":"Cytological changes in endotracheal aspirates associated with chronic lung disease"},{"title3":"Outcome of early-onset sepsis in a national cohort of very low birth weight infants"},{"title3":"Short- and long-term respiratory outcomes in neonates with ventilator-associated pneumonia"},{"title3":"Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association"},{"title3":"Systemic inflammation associated with mechanical ventilation among extremely preterm infants"},{"title3":"Long term consequences of oxygen therapy in the neonatal period"},{"title3":"Inflammatory response to oxygen and endotoxin in newborn rat lung ventilated with low tidal volume"},{"title3":"Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia"},{"title3":"Lung and systemic inflammation in preterm lambs on continuous positive airway pressure or conventional ventilation"},{"title3":"Recruited monocytes and type 2 immunity promote lung regeneration following pneumonectomy"},{"title3":"Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation"},{"title3":"Monocyte-derived alveolar macrophages: the dark side of lung repair?"},{"title3":"Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma"},{"title3":"Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome"},{"title3":"Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice"},{"title3":"Latent TGF-beta-binding proteins"},{"title3":"Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation"},{"title3":"Inhibiting NF-kappaB in the developing lung disrupts angiogenesis and alveolarization"},{"title3":"Sustained hyperoxia-induced NF-kappaB activation improves survival and preserves lung development in neonatal mice"},{"title3":"Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate"},{"title3":"Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to &gt;95% oxygen"},{"title3":"Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia"},{"title3":"Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia"},{"title3":"Superoxide dismutase 3 dysregulation in a murine model of neonatal lung injury"},{"title3":"Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies"},{"title3":"Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase"},{"title3":"Evidence of unexpected oxidative stress in airways of adolescents born very pre-term"},{"title3":"Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice"},{"title3":"Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat"},{"title3":"Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice"},{"title3":"Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia"},{"title3":"Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung"},{"title3":"Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis"},{"title3":"Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia"},{"title3":"Impact of Fgf10 deficiency on pulmonary vasculature formation in a mouse model of bronchopulmonary dysplasia"},{"title3":"Growth factors, postnatal lung growth and bronchopulmonary dysplasia"},{"title3":"WNT5a-ROR signaling is essential for alveologenesis"},{"title3":"The BPD trio? Interaction of dysregulated PDGF, VEGF, and TGF signaling in neonatal chronic lung disease"},{"title3":"A three-dimensional human model of the fibroblast activation that accompanies bronchopulmonary dysplasia identifies Notch-mediated pathophysiology"},{"title3":"A shared pattern of beta-catenin activation in bronchopulmonary dysplasia and idiopathic pulmonary fibrosis"},{"title3":"Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants"},{"title3":"Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs"},{"title3":"Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia"},{"title3":"Lung-specific inactivation of CCAAT/enhancer binding protein alpha causes a pathological pattern characteristic of COPD"},{"title3":"Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia"},{"title3":"Bronchopulmonary dysplasia"},{"title3":"Neonatal pulmonary hypertension"},{"title3":"Angiogenesis-related gene expression profiling in ventilated preterm human lungs"},{"title3":"Growth of pulmonary microvasculature in ventilated preterm infants"},{"title3":"Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity"},{"title3":"Pulmonary vascular dysfunction in preterm lambs with chronic lung disease"},{"title3":"Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells"},{"title3":"Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide. (LPS)-induced lung injury"},{"title3":"VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature"},{"title3":"Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia"},{"title3":"The extracellular matrix in bronchopulmonary dysplasia: target and source"},{"title3":"Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease"},{"title3":"Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition"},{"title3":"Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease"},{"title3":"Collagen scaffolding during development and its deformation with chronic lung disease"},{"title3":"Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia"},{"title3":"Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia"},{"title3":"Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia"},{"title3":"Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome"},{"title3":"Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia"},{"title3":"A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells"},{"title3":"A rapid lung de-cellularization protocol supports embryonic stem cell differentiation in vitro and following implantation"},{"title3":"Hallmarks of the ageing lung"},{"title3":"Early injury of the neonatal lung contributes to premature lung aging: a hypothesis"},{"title3":"Prevention of bronchopulmonary dysplasia"},{"title3":"Neonatal respiratory dysfunction and neuropsychological performance at the preschool age: a study of very preterm infants with bronchopulmonary dysplasia"},{"title3":"Lung consequences in adults born prematurely"},{"title3":"Patterns of growth and decline in lung function in persistent childhood asthma"},{"title3":"Improved survival prediction from lung function data in a large population sample"},{"title3":"Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance"},{"title3":"Lung function abnormalities in infants developing bronchopulmonary dysplasia"},{"title3":"Impact of airway obstruction on lung function in very preterm infants at term"},{"title3":"Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease"},{"title3":"Preschool healthcare utilisation related to home oxygen status"},{"title3":"Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease"},{"title3":"Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection"},{"title3":"Elevated carbon dioxide tension as a predictor of subsequent adverse events in infants with bronchopulmonary dysplasia"},{"title3":"Birth weight &lt;1501 g and respiratory health at age 14"},{"title3":"Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants"},{"title3":"Bronchopulmonary dysplasia: definitions and long-term respiratory outcome"},{"title3":"Risk factors for respiratory morbidity in infancy after very premature birth"},{"title3":"Effect of preterm birth on pulmonary function at school age: a prospective controlled study"},{"title3":"Very prematurely born infants wheezing at follow-up: lung function and risk factors"},{"title3":"Bronchial lability and responsiveness in school children born very preterm"},{"title3":"Relationship of symptoms to lung function abnormalities in preterm infants at follow-up"},{"title3":"The EPICure study: maximal exercise and physical activity in school children born extremely preterm"},{"title3":"Late pulmonary sequelae of bronchopulmonary dysplasia"},{"title3":"Lung volumes in infants who had mild to moderate bronchopulmonary dysplasia"},{"title3":"Lung function at term reflects severity of bronchopulmonary dysplasia"},{"title3":"Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence"},{"title3":"Respiratory and cardiovascular outcomes in survivors of extremely preterm birth at 19 years"},{"title3":"Lung function after preterm birth: development from mid-childhood to adulthood"},{"title3":"Chronic lung disease after premature birth"},{"title3":"The new bronchopulmonary dysplasia"},{"title3":"Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia"},{"title3":"Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice"},{"title3":"Medical history taking in adults should include questions about preterm birth"},{"title3":"From BPD to COPD? The hypothesis is intriguing but we lack lung pathology data in humans"}]},{"title2":"Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome","References":[]},{"title2":"The Deyo-Charlson and Elixhauser-van Walraven comorbidity indices as predictors of mortality in critically ill patients","References":[{"title3":"Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs"},{"title3":"Growth of intensive care unit resource use and its estimated cost in Medicare"},{"title3":"Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score Work"},{"title3":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases"},{"title3":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Comorbidity measures for use with administrative data"},{"title3":"Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012"},{"title3":"Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer"},{"title3":"Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality"},{"title3":"Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer"},{"title3":"Predictors of mortality and short-term physical and cognitive dependence in critically ill persons 75 years and older: a prospective cohort study"},{"title3":"Predicting hospital mortality in adult patients with prolonged stay (&gt;14 days) in surgical intensive care unit"},{"title3":"Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care"},{"title3":"Estimating long-term survival of critically ill patients: the PREDICT model"},{"title3":"Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients"},{"title3":"Systematic review of comorbidity indices for administrative data"},{"title3":"Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data"},{"title3":"A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data"},{"title3":"The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach"},{"title3":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond"},{"title3":"One-year survival and resource use after critical illness: impact of organ failure and residual organ dysfunction in a cohort study in Brazil"},{"title3":"Surviving intensive care: a systematic review of healthcare resource use after hospital discharge*"}]},{"title2":"Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database","References":[{"title3":"Acute respiratory distress syndrome"},{"title3":"Functional disability 5 years after acute respiratory distress syndrome"},{"title3":"Physical declines occurring after hospital discharge in ARDS survivors: a 5-year longitudinal study"},{"title3":"Pharmacological treatments in ARDS; a state-of-the-art update"},{"title3":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials"},{"title3":"The diabetes pandemic"},{"title3":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030"},{"title3":"Management of critically ill patients with type 2 diabetes: the need for personalised therapy"},{"title3":"Diabetic patients have a decreased incidence of acute respiratory distress syndrome"},{"title3":"Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion"},{"title3":"Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study"},{"title3":"The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study"},{"title3":"Acute lung injury prediction score: derivation and validation in a population-based sample"},{"title3":"Role of diabetes in the development of acute respiratory distress syndrome"},{"title3":"Derivation and diagnostic accuracy of the surgical lung injury prediction model"},{"title3":"In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study"},{"title3":"Insulin-treated diabetes is not associated with increased mortality in critically ill patients"},{"title3":"Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis"},{"title3":"Diabetes mellitus does not adversely affect outcomes from a critical illness"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Early identification of patients at risk of acute lung injury"},{"title3":"Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: a meta-analysis"},{"title3":"Blood glucose concentration and outcome of critical illness: the impact of diabetes"},{"title3":"Liberal glucose control in ICU patients with diabetes: a before-and-after study"},{"title3":"Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis"},{"title3":"Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the Fremantle diabetes study"},{"title3":"Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study"},{"title3":"Clinical predictors of hospital mortality differ between direct and indirect ARDS"},{"title3":"Diabetes, insulin, and development of acute lung injury"},{"title3":"Modulation of the glycemic response using insulin attenuates the pulmonary response in an animal trauma model"},{"title3":"Insulin attenuates endotoxin-induced acute lung injury in conscious rats"},{"title3":"Modulation of lipopolysaccharide-induced acute lung inflammation: role of insulin"},{"title3":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury"},{"title3":"Metformin-stimulated AMPK-alpha1 promotes microvascular repair in acute lung injury"},{"title3":"Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis"},{"title3":"Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial"},{"title3":"Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes"}]},{"title2":"The effect of diabetes on the risk and mortality of acute lung injury/acute respiratory distress syndrome: a meta-analysis","References":[{"title3":"Overview of current lung imaging in acute respiratory distress syndrome"},{"title3":"Current concepts of ARDS: a narrative review"},{"title3":"Incidence and recognition of acute respiratory distress syndrome in a UK intensive care unit"},{"title3":"Early paralysis for the management of ARDS"},{"title3":"Past and present ARDS mortality rates: a systematic review"},{"title3":"The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis"},{"title3":"Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion"},{"title3":"Role of diabetes in the development of acute respiratory distress syndrome"},{"title3":"Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: a meta-analysis"},{"title3":"Derivation and diagnostic accuracy of the surgical lung injury prediction model"},{"title3":"Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study"},{"title3":"Risk factors and outcomes of acute respiratory distress syndrome in critically ill patients with cirrhosis"},{"title3":"Quantifying heterogeneity in a meta-analysis"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Operating characteristics of a rank correlation test for publication bias"},{"title3":"Bias in meta-analysis detected by a simple, graphical test"},{"title3":"Diabetic patients have a decreased incidence of acute respiratory distress syndrome"},{"title3":"Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study"},{"title3":"Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study"},{"title3":"Acute lung injury prediction score: derivation and validation in a population-based sample"},{"title3":"Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China"},{"title3":"In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study"},{"title3":"Effect of type II diabetes mellitus on outcomes in patients with acute respiratory distress syndrome"},{"title3":"The outcome of acute respiratory distress syndrome in relation to body mass index and diabetes mellitus"},{"title3":"Clinical predictors of hospital mortality differ between direct and indirect ARDS"},{"title3":"Diabetes mellitus: a negative predictor for the development of acute respiratory distress syndrome from septic shock"},{"title3":"alpha1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice"}]},{"title2":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","References":[]},{"title2":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome","References":[]},{"title2":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome","References":[]},{"title2":"T cell-mediated immune response to respiratory coronaviruses","References":[{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio. 2012;3(6):e00473-12."},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Severe acute respiratory syndrome"},{"title3":"A long-term study of the pathogenesis of infection of fowls with three strains of avian infectious bronchitis virus"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV):update. 2014. http://www.who.int/csr/don/2014_03_25/en/."},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol. 2014. doi:10.1016/j.jcpa.2014.01.004."},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Animal models for influenza virus pathogenesis and transmission"},{"title3":"Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus"},{"title3":"Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells"},{"title3":"Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo"},{"title3":"Memory CD8 T-cell differentiation during viral infection"},{"title3":"Gene modulation and immunoregulatory roles of interferon gamma"},{"title3":"CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function"},{"title3":"Regulation of memory CD4 T cells: generation, localization and persistence"},{"title3":"Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial"},{"title3":"Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"[Study on T cell subsets and their activated molecules from the convalescent SARS patients during two follow-up surveys]. Xi bao yu fen zi mian yi xue za zhi ="},{"title3":"[Change of T lymphocyte and its activated subsets in SARS patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells"},{"title3":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections"},{"title3":"Immunological responses against SARS-coronavirus infection in humans"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Oh H-L, Gan S, Bertoletti A, Tan Y-J. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect. 2012;1:e23-8."},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine"},{"title3":"Vaccination of mice with DNA vaccine induces the immune response and partial protection against T. spiralis infection"},{"title3":"Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Cockrell AS, Peck KM, Yount BL, Agnihothram SS, Scobey T, Curnes NR, Baric RS, Heise MT. Mouse dipeptidyl peptidase 4 (DPP4) is not a functional receptor for Middle East respiratory syndrome coronavirus (MERS-CoV) infection. J Virol. 2014;88:5195-9."},{"title3":"Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Zhao J, Gale MJ Jr, Baric RS, Enjuanes L, Gallagher T, McCray PB Jr, Perlman S. Rapid generation of a mouse model for Middle East respiratory syndrome. In: Proceedings of the national academy of sciences of the United States of America; 2014."},{"title3":"Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome"},{"title3":"Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice"},{"title3":"T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts"},{"title3":"CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch"},{"title3":"Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory"},{"title3":"Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells"},{"title3":"Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Response of aged mice to primary virus infections"},{"title3":"Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population"},{"title3":"The multiple personalities of the chemokine receptor CCR7 in dendritic cells"},{"title3":"Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response"},{"title3":"Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies"},{"title3":"Mouse hepatitis virus type 4 (JHM strains) induced fatal central nervous system disease. I. Genetic control and murine neuron as the susceptible site of disease"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination"},{"title3":"Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection"},{"title3":"Th17 lymphocytes in respiratory syncytial virus infection"},{"title3":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice"},{"title3":"Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry"},{"title3":"Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection"},{"title3":"Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection"},{"title3":"Strutt TM, McKinstry KK, Dibble JP, Winchell C, Kuang Y, Curtis JD, Huston G, Dutton RW, Swain SL. Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med. 2010. 16:558-564, 551 p following 564."},{"title3":"Sensing and alarm function of resident memory CD8(+) T cells"},{"title3":"Immunity to respiratory viruses"},{"title3":"T cell memory in the lung airways"},{"title3":"Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus"},{"title3":"Cellular immune correlates of protection against symptomatic pandemic influenza"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Human memory T cell responses to SARS-CoV E protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys"},{"title3":"Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine"},{"title3":"Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection"},{"title3":"Differential regulation of primary and secondary CD8+ T cells in the central nervous system"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Memory T cells protect chicks from acute infectious bronchitis virus infection"},{"title3":"Adoptive transfer of infectious bronchitis virus primed alphabeta T cells bearing CD8 antigen protects chicks from acute infection"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"SARS coronavirus nucleocapsid immunodominant T cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens"}]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis","References":[]},{"title2":"Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Update: outbreak of severe acute respiratory syndrome:worldwide, 2003"},{"title3":"Outbreak of severe acute respiratory syndrome:worldwide, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS):multi-country outbreak. Available at: http://www.who.int/csr/don/2003_03_15/en/. Accessed 15 March 2003."},{"title3":"Outbreak of severe acute respiratory syndrome:worldwide, 2003"},{"title3":"World Health Organization. Cumulative number of reported probable cases of SARS. Available at: http://www.who.int/csr/sars/country/2003_07_04/en/. Accessed 4 July 2003."},{"title3":"Control measures for severe acute respiratory syndrome (SARS) in Taiwan"},{"title3":"Severe acute respiratory syndrome:Taiwan, 2003"},{"title3":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/. Accessed 1 May 2003."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Practice guidelines for the management of community-acquired pneumonia in adults"},{"title3":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention"},{"title3":"World Health Organization. Update 96-Taiwan, China: SARS transmission interrupted in last outbreak area. Available at: http://www.who.int/csr/don/2003_07_05/en/. Accessed 5 July 2003."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Koch's postulates fulfilled for SARS virus"},{"title3":"Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome in Singapore: clinical features of index patient and initial contacts"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"The use of corticosteroids in SARS"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"}]},{"title2":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome","References":[]},{"title2":"SARS in Singapore-predictors of disease severity","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical issues and research in respiratory failure from severe acute respiratory syndrome","References":[]},{"title2":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids","References":[]},{"title2":"Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge","References":[{"title3":"Consensus for the management of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Ministry of Chinese Public Health. Diagnosis standard, treatment proposal and discharge consulting criteria for severe acute respiratory syndrome"},{"title3":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience"},{"title3":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"How is type I procollagen synthesis regulated at the gene level during tissue fibrosis"},{"title3":"World Health Organization"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Updated interim U.S. case definition for severe acute respiratory syndrome (SARS)"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: prognosis, outcome and sequelae"}]},{"title2":"Follow-up chest radiographic findings in patients with MERS-CoV after recovery","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"World Health Organization. Global Alert and Response (GAR). Corona virus infections"},{"title3":"World Health Organization. Preliminary clinical description of severe acute respiratory syndrome"},{"title3":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome corona virus"},{"title3":"Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?"},{"title3":"Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients"},{"title3":"The significance of bronchial dilatation on CT in patients with adult respiratory distress syndrome"},{"title3":"Pulmonary fibrosis in severe acute respiratory failure"},{"title3":"State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) in Humans"},{"title3":"Severe acute respiratory syndrome: Radiographic appearances and pattern of progression in 138 patients"},{"title3":"Thin-section CT of severe acute respiratory syndrome: Evaluation of 73 patients exposed to or with the disease"},{"title3":"Fleischner Society: Glossary of terms for thoracic imaging"},{"title3":"SARS: Radiological features"},{"title3":"Glossary of terms for CT of the lungs: Recommendations of the Nomenclature Committee of the Fleischner Society"},{"title3":"Mediastinum"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: Temporal lung changes at thin-section CT in 30 patients"},{"title3":"Viruses, mycoplasmas, chlamydiae, and rickettsiae"},{"title3":"Post-ARDS lung fibrosis in patients with H1N1 pneumonia: Role of follow-up CT"},{"title3":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: Preliminary experience"},{"title3":"Viral infection and aging as cofactors for the development of lung fibrosis"},{"title3":"Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation"},{"title3":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis"}]},{"title2":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis","References":[{"title3":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis"},{"title3":"Understanding of COVID-19 based on current evidence"}]}]},{"title1":"Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells","References":[{"title2":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Protease inhibitors targeting coronavirus and filovirus entry","References":[{"title3":"Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor"},{"title3":"Mining a cathepsin inhibitor library for new antiparasitic drug leads"},{"title3":"A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi"},{"title3":"Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium"},{"title3":"Chemical-biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target"},{"title3":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Role of endocytosis and cathepsin-mediated activation in Nipah virus entry"},{"title3":"Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment"},{"title3":"Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression"},{"title3":"Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors"},{"title3":"Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate"},{"title3":"In vitro evaluation of the disposition of a novel cysteine protease inhibitor"},{"title3":"Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences"},{"title3":"A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection"},{"title3":"A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L"},{"title3":"Vinyl sulfones as mechanism-based cysteine protease inhibitors"},{"title3":"Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K"},{"title3":"Keto-1,3,4-oxadiazoles as cathepsin K inhibitors"},{"title3":"Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors"},{"title3":"Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease"},{"title3":"Characterization of Chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein"},{"title3":"Filoviruses utilize glycosaminoglycans for their attachment to target cells"},{"title3":"Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research"},{"title3":"Characterization of the Bas-Congo virus glycoprotein and its function in pseudotyped viruses"},{"title3":"Fiopan  Tablets [package insert]. Ono Pharmaceutical Co., Ltd, Chuo-ku, Osaka, Japan; August 2009."},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Development of novel entry inhibitors targeting emerging viruses"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"Inhibitors of SARS-CoV entry - identification using an internally-controlled dual envelope pseudovirion assay"},{"title3":"Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors"}]},{"title2":"Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study","References":[]},{"title2":"Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19","References":[{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Lysosomal Proteases Are a Determinant of Coronavirus Tropism"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A brief history of autophagy from cell biology to physiology and disease"},{"title3":"Biological Functions of Autophagy Genes: A Disease Perspective"},{"title3":"Autophagy: machinery and regulation"},{"title3":"The ATG conjugation systems in autophagy"},{"title3":"Autophagy in mammalian development and differentiation"},{"title3":"Autophagy in human health and disease"},{"title3":"Autophagy: regulation and role in disease"},{"title3":"Autophagy and human diseases"},{"title3":"Autophagy: a lysosomal degradation pathway with a central role in health and disease"},{"title3":"At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy"},{"title3":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism"},{"title3":"The lysosome as a cellular centre for signalling, metabolism and quality control"},{"title3":"Lysosomal acidification mechanisms"},{"title3":"Proteomics of the lysosome"},{"title3":"To degrade or not to degrade: mechanisms and significance of endocytic recycling"},{"title3":"The enigmatic endosome - sorting the ins and outs of endocytic trafficking"},{"title3":"Endocytic membrane trafficking and neurodegenerative disease"},{"title3":"Endosomal vesicles as vehicles for viral genomes"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins"},{"title3":"Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication"},{"title3":"Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain"},{"title3":"Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity"},{"title3":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells"},{"title3":"Significance of lysosomes in the morphogenesis of coronaviruses"},{"title3":"Infectious bronchitis virus entry mainly depends on clathrin mediated endocytosis and requires classical endosomal/lysosomal system"},{"title3":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway"},{"title3":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells"},{"title3":"Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry"},{"title3":"Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry"},{"title3":"Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level"},{"title3":"Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15"},{"title3":"Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner"},{"title3":"ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells"},{"title3":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)"},{"title3":"Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism"},{"title3":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents"},{"title3":"New insights into the antiviral effects of chloroquine"},{"title3":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response"},{"title3":"Advances in clinical diagnosis and treatment of severe acute respiratory syndrome"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology"},{"title3":"[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a 2 clinically-proven protease inhibitor Cell"},{"title3":"Classics in Chemical Neuroscience: Chlorpromazine"}]},{"title2":"Clathrin-dependent entry of severe acute respiratory syndrome corona virus into target cells express-ing ACE2 with the cytoplasmic tail deleted","References":[]},{"title2":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","References":[{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"World Health Organization: Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol (revised May 1, 2003, and accessed May 10, 2003)"},{"title3":"The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"Tissue and cellular tropisms of the coronavirus associated with severe acute respiratory syndrome:An in-situ hybridization study of fatal cases"},{"title3":"Severe acute respiratory syndrome: Clinical outcome and prognostic correlates"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Severe acute respiratory syndrome in haemodialysis patients: A report of two cases"},{"title3":"Severe acute respiratory syndrome in a haemodialysis patient"},{"title3":"The clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients"},{"title3":"Clinical, laboratory, and radiologic manifestation of SARS"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"}]},{"title2":"Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein","References":[]},{"title2":"ACE2 alterations in kidney disease","References":[]},{"title2":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease","References":[]},{"title2":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong","References":[{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Coronavirus never before seen in humans is the cause of SARS. www.who.int/mediacentre/releases/2003/pr31/en/ (accessed May 5, 2003)."},{"title3":"Hong Kong Hospital Authority. www.ha.org.hk (accessed May 5, 2003)."},{"title3":"Department of Health, Hong Kong Government of Special Administrative Region website. http://www.info.gov.hk/dh/ (accessed May 5, 2003)."},{"title3":"Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. http://content.nejm.org/cgi/reprint/NEJMoa030666v3.pdf (accessed May 5, 2003)."},{"title3":"WHO. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). www.who.int/csr/sarscountry/en/ (accessed May 5, 2003)."}]},{"title2":"Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues","References":[]},{"title2":"The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma","References":[]},{"title2":"Diabetes, hypertension, and chronic kidney disease progression: Role of DPP4","References":[]},{"title2":"Association of Na(+)-H(+) exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule","References":[]},{"title2":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","References":[{"title3":"Host factors in positive-strand RNA virus genome replication"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Virus entry, assembly, budding, and membrane rafts"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Xin Zou, K.C., Jiawei Zou, Peiyi Han, Jie Hao, Zeguang Han, The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. [Epub ahead of print] doi: 10.1007/s11684-020-0754-0."},{"title3":"Cell membrane proteins with high N-glycosylation, high expression and multiple interaction partners are preferred by mammalian viruses as receptors"},{"title3":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis"},{"title3":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations"},{"title3":"Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine"},{"title3":"Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis"},{"title3":"Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry"},{"title3":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report"},{"title3":"scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation"},{"title3":"Colonic epithelial cell diversity in health and inflammatory bowel disease"},{"title3":"Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration"},{"title3":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer"},{"title3":"Single-cell RNA sequencing of human kidney"},{"title3":"Comprehensive integration of single-cell data"},{"title3":"Fast, sensitive and accurate integration of single-cell data with harmony"},{"title3":"Membranome: a database for proteome-wide analysis of single-pass membrane proteins"},{"title3":"Mammalian Glutamyl aminopeptidase genes (ENPEP) and proteins: comparative studies of a major contributor to arterial hypertension"},{"title3":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies"},{"title3":"Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV). World Health Organization, Retrieved 10 April 2017."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus"},{"title3":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus"},{"title3":"Permissivity of dipeptidyl peptidase 4 orthologs to Middle East respiratory syndrome coronavirus is governed by glycosylation and other complex determinants"},{"title3":"Interferon activation and innate immunity"},{"title3":"The host type I interferon response to viral and bacterial infections"},{"title3":"Type I interferons in infectious disease"},{"title3":"MHC class I antigen presentation: learning from viral evasion strategies"},{"title3":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication"}]},{"title2":"functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","References":[]},{"title2":"The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike","References":[]},{"title2":"Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease"},{"title3":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters"},{"title3":"Wild type and innate immune deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus"},{"title3":"No susceptibility of neonatal and adult rats against the Middle East respiratory syndrome coronavirus"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"CD8+ T cells and macrophages regulate pathogenesis in a mouse model of Middle East respiratory syndrome"},{"title3":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the republic of Korea, 2015"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Transgenic mice susceptible to poliovirus"},{"title3":"Transgenic mouse model for the study of enterovirus 71 neuropathogenesis"},{"title3":"Overview: engineering transgenic constructs and mice"},{"title3":"Accessory cell signals involved in T-cell activation"},{"title3":"CD26: a surface protease involved in T-cell activation"},{"title3":"The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity"},{"title3":"A human DPP4-knockin mouse's susceptibility to infection by authentic and pseudotyped MERS-CoV"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Pathogenesis of Middle East respiratory syndrome coronavirus"},{"title3":"Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine"},{"title3":"Middle East respiratory syndrome coronavirus infections in health care workers"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Estimation of severe Middle East respiratory syndrome cases in the Middle East, 2012-2016"},{"title3":"A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Multifacility outbreak of Middle East respiratory syndrome in Taif, Saudi Arabia"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"One site mutation disrupts dimer formation in human DPP-IV proteins"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Immune responses to MERS coronavirus during the acute and convalescent phases of human infection"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection"}]},{"title2":"In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Latest outbreak news from ProMED-mail: novel coronavirus - Middle East"},{"title3":"State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans"},{"title3":"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues"},{"title3":"Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission"}]},{"title2":"Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence","References":[{"title3":"Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins"},{"title3":"Replication of coronavirus mhv-a59 in sac- cells: Determination of the first site of budding of progeny virions"},{"title3":"Ultrastructure of sars-cov, fipv, and mhv revealed by electron cryomicroscopy"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"Architecture of the sars coronavirus prefusion spike"},{"title3":"Crystal structure of nl63 respiratory coronavirus receptor-binding domain complexed with its human receptor"},{"title3":"Structure of sars coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor"},{"title3":"Mechanisms of host receptor adaptation by sars coronavirus"},{"title3":"haracterization of the heptad repeat regions, hr1 and hr2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (sars) coronavirus"},{"title3":"Structures and polymorphic interactions of two heptad-repeat regions of the sars virus s2 protein"},{"title3":"Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core"},{"title3":"Core structure of s2 from the human coronavirus nl63 spike glycoprotein"},{"title3":"A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses"},{"title3":"Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the sars coronavirus spike glycoprotein"},{"title3":"Structural basis of viral invasion: Lessons from paramyxovirus f"},{"title3":"Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein"},{"title3":"Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein s2 domain with characteristics of a viral fusion peptide"},{"title3":"Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry"},{"title3":"Importance of sars-cov spike protein trp-rich region in viral infectivity"},{"title3":"Mutational analysis of the murine coronavirus spike protein: Effect on cell-to-cell fusion"},{"title3":"Palmitoylation of the cysteine-rich endodomain of the sars-coronavirus spike glycoprotein is important for spike-mediated cell fusion"},{"title3":"Role of spike protein endodomains in regulating coronavirus entry"},{"title3":"The coronavirus spike protein is a class i virus fusion protein: Structural and functional characterization of the fusion core complex"},{"title3":"Structural characterization of the sars-coronavirus spike s fusion protein core"},{"title3":"Severe acute respiratory syndrome coronavirus (sars-cov) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"Identification of a minimal peptide derived from heptad repeat (hr) 2 of spike protein of sars-cov and combination of hr1-derived peptides as fusion inhibitors"},{"title3":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of sars-associated coronavirus"},{"title3":"Conformational change of the coronavirus peplomer glycoprotein at ph 8.0 and 37 degrees c correlates with virus aggregation and virus-induced cell fusion"},{"title3":"A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor"},{"title3":"The hydrophobic domain of infectious bronchitis virus e protein alters the host secretory pathway and is important for release of infectious virus"},{"title3":"Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein"},{"title3":"Sars coronavirus e protein forms cation-selective ion channels"},{"title3":"Absence of e protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Identification of a ph sensor in the furin propeptide that regulates enzyme activation"},{"title3":"Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion"},{"title3":"Fusion-defective mutants of mouse hepatitis virus a59 contain a mutation in the spike protein cleavage signal"},{"title3":"Acquired fusion activity of a murine coronavirus mhv-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the s protein"},{"title3":"Proteolytic cleavage of the e2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion"},{"title3":"Furin cleavage of the sars coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry"},{"title3":"Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor"},{"title3":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ace2 with the cytoplasmic tail deleted"},{"title3":"Requirements for ceacams and cholesterol during murine coronavirus cell entry"},{"title3":"Receptor-independent infection of murine coronavirus: Analysis by spinoculation"},{"title3":"N-terminal domain of the murine coronavirus receptor ceacam1 is responsible for fusogenic activation and conformational changes of the spike protein"},{"title3":"Receptor-induced conformational changes of murine coronavirus spike protein"},{"title3":"Receptor and viral determinants of sars-coronavirus adaptation to human ace2"},{"title3":"Synthetic recombinant bat sars-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted rna secondary structure"},{"title3":"Pathogenesis of neurotropic murine coronavirus is multifactorial"},{"title3":"Evolution and tropism of transmissible gastroenteritis coronavirus"},{"title3":"Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (n-glycolylneuraminic acid) binding activity"},{"title3":"Genetic evolution and tropism of transmissible gastroenteritis coronaviruses"},{"title3":"Two amino acid changes at the n-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism"},{"title3":"Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees c either by soluble murine ceacam1 receptors or by ph 8"},{"title3":"Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis"},{"title3":"Single amino acid changes in the s2 subunit of the mhv surface glycoprotein confer resistance to neutralization by s1 subunit-specific monoclonal antibody"},{"title3":"Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain jhm, is associated with a glycine at residue 310 of the spike glycoprotein"},{"title3":"Cooperative involvement of the s1 and s2 subunits of the murine coronavirus spike protein in receptor binding and extended host range"},{"title3":"Communication between s1n330 and a region in s2 of murine coronavirus spike protein is important for virus entry into cells expressing ceacam1b receptor"},{"title3":"Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion"},{"title3":"Viral entry"},{"title3":"Sfv infection in cho cells: Cell-type specific restrictions to productive virus entry at the cell surface"},{"title3":"Alteration of the ph dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein"},{"title3":"Control of virus-induced cell fusion by host cell lipid composition"},{"title3":"Hiv enters cells via endocytosis and dynamin-dependent fusion with endosomes"},{"title3":"Dissecting virus entry via endocytosis"},{"title3":"Human coronavirus 229e binds to cd13 in rafts and enters the cell through caveolae"},{"title3":"Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release"},{"title3":"Clathrin- and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin"},{"title3":"Sars coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway"},{"title3":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a ph- and cysteine protease-independent fcgammar pathway"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (sars-cov) spike glycoprotein-mediated viral entry"},{"title3":"Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry"},{"title3":"Inhibitors of cathepsin l prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Structure and function of the complete internal fusion loop from ebolavirus glycoprotein 2"},{"title3":"Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus s2-hr2"},{"title3":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection"},{"title3":"Endosomal proteolysis of the ebola virus glycoprotein is necessary for infection"},{"title3":"Cathepsin l functionally cleaves the severe acute respiratory syndrome coronavirus class i fusion protein upstream of rather than adjacent to the fusion peptide"},{"title3":"Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved s protein as revealed by pseudotype virus bearing cleaved s protein"},{"title3":"Proteolytic activation of the spike protein at a novel rrrr/s motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells"},{"title3":"Activation of the sars coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"Cleavage of the sars coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease tmprss2"},{"title3":"Evidence that tmprss2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"Membrane-anchored serine proteases in vertebrate cell and developmental biology"},{"title3":"Type ii transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes"},{"title3":"Cloning of the tmprss2 gene, which encodes a novel serine protease with transmembrane, ldlra, and srcr domains and maps to 21q22.3"},{"title3":"Phenotypic analysis of mice lacking the tmprss2-encoded protease"},{"title3":"Proteolytic activation of influenza viruses by serine proteases tmprss2 and hat from human airway epithelium"},{"title3":"Proteolytic activation of the 1918 influenza virus hemagglutinin"},{"title3":"Cleavage of influenza virus hemagglutinin by airway proteases tmprss2 and hat differs in subcellular localization and susceptibility to protease inhibitors"},{"title3":"Novel type ii transmembrane serine proteases, mspl and tmprss13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication"},{"title3":"Sars coronavirus, but not human coronavirus nl63, utilizes cathepsin l to infect ace2-expressing cells"},{"title3":"The spike protein of sars-cov--a target for vaccine and therapeutic development"},{"title3":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Recombinant modified vaccinia virus ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region"},{"title3":"Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (sars) coronavirus s protein neutralizes the virus in a rhesus macaque sars model"},{"title3":"Isolation and characterization of griffithsin, a novel hiv-inactivating protein, from the red alga griffithsia sp."},{"title3":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family coronaviridae"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"Antiviral activity of carbohydrate-binding agents against nidovirales in cell culture"},{"title3":"A small-molecule oxocarbazate inhibitor of human cathepsin l blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293t cells"},{"title3":"Inhibition of lung serine proteases in mice: A potentially new approach to control influenza infection"},{"title3":"Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses"},{"title3":"clinical effectiveness of aprotinin aerosol in influenza and parainfluenza"},{"title3":"Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease tmprss2"},{"title3":"Following the rule: Formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors"},{"title3":"Strong in vitro synergy between the fusion inhibitor t-20 and the cxcr4 blocker amd-3100"},{"title3":"Coronavirus escape from heptad repeat 2 (hr2)-derived peptide entry inhibition as a result of mutations in the hr1 domain of the spike fusion protein"}]},{"title2":"Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner","References":[{"title3":"Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner"}]},{"title2":"Lysosomal physiology","References":[{"title3":"Structure and gating of CLC channels and exchangers"},{"title3":"Separate ion pathways in a Cl-/H+ exchanger"},{"title3":"Channel-like slippage modes in the human anion/proton exchanger ClC-4"},{"title3":"The lysosome: from waste bag to potential therapeutic target"},{"title3":"A CLC-ec1 mutant reveals global conformational change and suggests a unifying mechanism for the CLC Cl-/H+ transport cycle"},{"title3":"A single point mutation reveals gating of the human ClC-5 Cl-/H+ antiporter"},{"title3":"Shared Molecular Mechanisms of Membrane Transporters"},{"title3":"Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle"},{"title3":"The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes"},{"title3":"ClC-3 is an intracellular chloride/proton exchanger with large voltage-dependent nonlinear capacitance"},{"title3":"Lipids and lysosomes"},{"title3":"A model of lysosomal pH regulation"},{"title3":"CLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease"},{"title3":"Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration"},{"title3":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man"},{"title3":"ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function"},{"title3":"ClC-7 is a slowly voltage-gated 2Cl(-)/1H(+)-exchanger and requires Ostm1 for transport activity"},{"title3":"Intracellular proton-transfer mutants in a CLC Cl-/H+ exchanger"},{"title3":"Intracellular proton access in a Cl(-)/H(+) antiporter"},{"title3":"Common gating of both CLC transporter subunits underlies voltage-dependent activation of the 2Cl-/1H+ exchanger ClC-7/Ostm1"},{"title3":"A mathematical model of osteoclast acidification during bone resorption"},{"title3":"Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent"},{"title3":"Open-state substructure of single chloride channels from Torpedo electroplax"},{"title3":"The late endosomal ClC-6 mediates proton/chloride countertransport in heterologous plasma membrane expression"},{"title3":"Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification"},{"title3":"Anion- and proton-dependent gating of ClC-4 anion/proton transporter under uncoupling conditions"},{"title3":"Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5"},{"title3":"Lysosomal storage diseases"},{"title3":"Large transient capacitive currents in wild-type lysosomal Cl-/H+ antiporter ClC-7 and residual transport activity in the proton glutamate mutant E312A"},{"title3":"Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins"},{"title3":"Cryo-EM structure of the lysosomal chloride-proton exchanger CLC-7 in complex with OSTM1"},{"title3":"Voltage-dependent charge movement associated with activation of the CLC-5 2Cl-/1H+ exchanger"},{"title3":"A cation counterflux supports lysosomal acidification"},{"title3":"Transport activity and presence of ClC-7/Ostm1 complex account for different cellular functions"},{"title3":"Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation"},{"title3":"Regulation of lysosomal ion homeostasis by channels and transporters"},{"title3":"PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel"},{"title3":"Determinants of anion-proton coupling in mammalian endosomal CLC proteins"},{"title3":"Molecular insights into the human CLC-7/Ostm1 transporter"},{"title3":"On the mechanism of gating charge movement of ClC-5, a human Cl(-)/H(+) antiporter"}]},{"title2":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","References":[{"title3":"The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases"},{"title3":"ACE2/Ang-(1-7)/Mas pathway in the brain: The Axis of Good"},{"title3":"Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice"},{"title3":"Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy"},{"title3":"Brain ACE2 Shedding Contributes to the Development of Neurogenic Hypertension"},{"title3":"Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension"},{"title3":"ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function"},{"title3":"Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats"},{"title3":"Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats"},{"title3":"b-arrestin-mediated receptor trafficking and signal transduction"},{"title3":"Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway"},{"title3":"A story of two ACEs"},{"title3":"beta-Site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice"},{"title3":"Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted"},{"title3":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway"},{"title3":"Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis"},{"title3":"Endosomal transport via ubiquitination"},{"title3":"Brain-Selective Overexpression of Angiotensin-Converting Enzyme 2 Attenuates Sympathetic Nerve Activity and Enhances Baroreflex Function in Chronic Heart Failure"},{"title3":"Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer"},{"title3":"Activation of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis Enhances the Reparative Function of Dysfunctional Diabetic Endothelial Progenitors"},{"title3":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats"},{"title3":"ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts"},{"title3":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR"},{"title3":"Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology"},{"title3":"Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice"},{"title3":"Angiotensin-I Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice"},{"title3":"Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation"},{"title3":"Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes"},{"title3":"Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats"},{"title3":"Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure"},{"title3":"Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling"},{"title3":"Aerobic Exercise Training-Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7)"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain"},{"title3":"Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?"},{"title3":"Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes"},{"title3":"Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion"},{"title3":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system"},{"title3":"Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus"},{"title3":"The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors"},{"title3":"Intracellular Angiotensin II and cell growth of vascular smooth muscle cells"},{"title3":"ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension"},{"title3":"Angiotensin-Converting Enzyme 2 Overexpression Improves Central Nitric Oxide Mediated Sympathetic Outflow in Chronic Heart Failure"}]},{"title2":"Kidney disease is associated with in-hospital death of patients with COVID-19","References":[]},{"title2":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Glucosuria predicts the severity of Puumala hantavirus infection"},{"title3":"ANCA small-vessel vasculitis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection [e-pub ahead of print]. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2020.03.047. Accessed March 28, 2020."},{"title3":"The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"ACE and ACE2 in kidney disease"},{"title3":"Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats"},{"title3":"Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. doi:10.1101/2020.03.14.988345. Accessed March 28, 2020."},{"title3":"Suppression of coronavirus replication by cyclophilin inhibitors"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"}]}]},{"title1":"Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China","References":[{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan, China the mystery and the miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China 2019","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China a descriptive study","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Optimum methodology for estimating baseline serum creatinine for the acute kidney injury classification","References":[]},{"title2":"The comparison of the commonly used surrogates for baseline renal function in acute kidney injury diagnosis and staging","References":[{"title3":"Epidemiology of acute kidney injury"},{"title3":"Sniffing out acute kidney injury in the ICU: do we have the tools?"},{"title3":"Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: a systematic review and meta-analysis"},{"title3":"Thongprayoon C, Cheungpasitporn W, Srivali N, Harrison AM, Gunderson TM, Kittanamongkolchai W, et al. AKI after Transcatheter or Surgical Aortic Valve Replacement. J Am Soc Nephrol 2015. [Epub ahead of print]."},{"title3":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients"},{"title3":"The RIFLE criteria and mortality in acute kidney injury: A systematic review"},{"title3":"Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria"},{"title3":"Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients"},{"title3":"Long-term outcomes and prognostic factors for patients requiring renal replacement therapy after cardiac surgery"},{"title3":"Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis"},{"title3":"KDIGO Clinical Practice Guidelines for Acute Kidney Injury"},{"title3":"Optimum methodology for estimating baseline serum creatinine for the acute kidney injury classification"},{"title3":"Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P, Kittanamongkolchai W, Kashani K. The impact of fluid balance on diagnosis, staging and prediction of mortality in critically ill patients with acute kidney injury. J Nephrol. 2015. [Epub ahead of print]."},{"title3":"Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit"},{"title3":"A comparison of three methods to estimate baseline creatinine for RIFLE classification"},{"title3":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy"},{"title3":"The risk of acute renal failure in patients with chronic kidney disease"},{"title3":"Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease"},{"title3":"Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records"},{"title3":"Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness"},{"title3":"The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults"},{"title3":"An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status"},{"title3":"Baseline creatinine to define acute kidney injury: is there any consensus?"},{"title3":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis"},{"title3":"The calculation of baseline serum creatinine overestimates the diagnosis of acute kidney injury in patients undergoing cardiac surgery"},{"title3":"A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury"},{"title3":"Age-and gender-adjusted eGFR to estimate baseline creatinine for RIFLE criteria"},{"title3":"Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research"}]},{"title2":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","References":[{"title3":"WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed Janaury 30, 2020)"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis"},{"title3":"Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures"},{"title3":"Single-cell transcriptome analysis maps the developmental track of the human heart"},{"title3":"scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation"},{"title3":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer"},{"title3":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations"},{"title3":"Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy"},{"title3":"Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response"},{"title3":"Single-cell transcriptomic map of the human and mouse bladders"},{"title3":"Dimensionality reduction for visualizing single-cell data using UMAP"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"A protein complex in the brush-border membrane explains a Hartnup disorder allele"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Myocardial infarction increases ACE2 expression in rat and humans"}]},{"title2":"Caution on Kidney Dysfunctions of 2019-nCoV Patients","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","References":[{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"World Health Organization: Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol (revised May 1, 2003, and accessed May 10, 2003)"},{"title3":"The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"Tissue and cellular tropisms of the coronavirus associated with severe acute respiratory syndrome:An in-situ hybridization study of fatal cases"},{"title3":"Severe acute respiratory syndrome: Clinical outcome and prognostic correlates"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Severe acute respiratory syndrome in haemodialysis patients: A report of two cases"},{"title3":"Severe acute respiratory syndrome in a haemodialysis patient"},{"title3":"The clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients"},{"title3":"Clinical, laboratory, and radiologic manifestation of SARS"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"}]}]},{"title1":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[{"title2":"WHO. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. Jan 11, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.","References":[]},{"title2":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). November, 2019. https://www.who.int/emergencies/mers-cov/en/ (accessed Jan 19, 2020).","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"World Health Organization. Novel Coronavirus (2019-nCoV). Situation report-5. 25 January 2020. www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_4.","References":[]},{"title2":" www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11811/202001/P020200127544648420736.pdf (In Chinese).","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications","References":[{"title3":"Middle East respiratory syndrome - advancing the public health, and research agenda on MERS - lessons from the South Korea outbreak"},{"title3":"Kupferschmidt K. Did poor ventilation lead to MERS 'superspread' in Korea? Science 2015. Available at: http://news.sciencemag.org/asiapacific/2015/06/did-poor-ventilation-lead-mers-superspread-korea [last accessed October 2015]."},{"title3":"Current epidemiological situation of Middle East respiratory syndrome coronavirus clusters and implications for public health response in South Korea"},{"title3":"Middle East respiratory syndrome"},{"title3":"2015 MERS outbreak in Korea: hospital-to-hospital transmission"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Heterogeneities in the transmission of infectious agents: implications for the design of control programs"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): epidemiology and clinical features"},{"title3":"Spread of MERS to South Korea and China"},{"title3":"2014 MERS-CoV outbreak in Jeddah - a link to health care facilities"},{"title3":"Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea"},{"title3":"Infection control precautions for visitors to healthcare facilities"},{"title3":"Middle East respiratory syndrome in the Republic of Korea: transparency and communication are key"},{"title3":"Why the panic? South Korea's MERS response questioned"},{"title3":"A cloud adult: the Staphylococcus aureus-virus interaction revisited"},{"title3":"Middle East respiratory syndrome (MERS) in Asia: lessons gleaned from the South Korean outbreak"},{"title3":"Healthcare policy and healthcare utilization behavior to improve hospital infection control after the Middle East respiratory syndrome outbreak"},{"title3":"Emergency medical services in response to the Middle East respiratory syndrome outbreak in Korea"},{"title3":"Public health crisis response and establishment of a crisis communication system in South Korea: lessons learned from the MERS outbreak"},{"title3":"Lessons learned from Middle East respiratory syndrome coronavirus cluster in Korea"},{"title3":"Proposed master plan for reform of the national infectious disease prevention, and management system in Korea"}]},{"title2":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/.(accessed Jan 27, 2020)","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]}]}]}